Editas Medicine, Inc.
看多

EDIT - another genomics name that looks ready

261
All major gene editing stocks look like they're on the cusp of big moves higher. (See last post on NTLA)
NTLA - trend continuation likely


Zoomed in on the shorter time frame we have a trigger off the 618 4hr retrace. There's some overhead supply in the 50s for shorter term targets, but this is a long term play with much higher upside.
快照

Seeing similar in CRSP, but EDIT is showing a more significant breakout on the monthly time frame
Short term quick look at CRSP:
快照

NTLA is the leader in the sector right now, but that could change fast. I am long all three

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。